NeoCodex

company

About

NeoCodex is a human genetics-based biotechnology company specialized in providing biomaterials, analysis, and project development services.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€645K
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2002
Number Of Employee
11 - 50
Operating Status
Active

NeoCodex is providing a deeper understanding of the genetic roots of disease. Applying NeoCodex's breakthrough whole genome association study (WGAS) technology, genomic services and biomaterials, researchers are gaining a clearer path to creating tomorrow's medicines through uncovering a greater understanding of human genetics and genetic variability.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€645K
NeoCodex has raised a total of €645K in funding over 2 rounds. Their latest funding was raised on Mar 29, 2006 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2006 Series Unknown €645K 1 Invercaria Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NeoCodex is funded by 1 investors. Invercaria are the most recent investors.
Investor Name Lead Investor Funding Round
Invercaria Yes Series Unknown